Canaccord Genuity Downgrades Stryker to Hold, Cuts Target to $300
Canaccord Genuity lowered its Stryker price target to $300 from $385. The new target implies 3.8% downside from the Oct. 29 close of $311.75.
Canaccord Genuity lowered its Stryker price target to $300 from $385. The new target implies 3.8% downside from the Oct. 29 close of $311.75.